Pharma
Analytics for clinical development strategy: Integrated optimization of an oncology program
Achieving a return on invested capital (ROIC) that exceeds the cost of capital remains a challenge for pharmaceutical R&D. To make progress, there needs to be consistent and rigorous modeling of the clinical and commercial determinants of ROIC. In the second of three articles, CRA’...
CMS’ Alzheimer’s NCD: Outlier or harbinger of increased scrutiny?
Aduhelm was the first FDA-approved disease-modifying treatment for Alzheimer’s, sparking debate among providers, regulators, and patients. Aduhelm received a controversial accelerated approval from the FDA in June 2021, a decision that balanced the lack of consensuses among the scientif...
Analytics for clinical development strategy: A unified approach to optimizing return on investment in R&D
Despite the rapid scientific advances with new targets, modalities, and biomarkers, the return on invested capital (ROIC) in novel therapeutics remains low. The problem stems from the large investment needed, high risks of failure, and long timelines until revenues can be realized. This...
Infertility - A public health concern
The World Health Organization (WHO) estimates that one out of six people globally are impacted by the inability to conceive a child. Over the last decade, countries around the world have seen a decline in total fertility rates, most notably in economically developed countries withi...
Glox Therapeutics awarded £1M PACE grant to accelerate development of precision antibiotics against antimicrobial-resistant pathogens
Novel therapeutics to address unmet clinical need for pneumonias caused by drug-resistant Escherichia coli and Klebsiella pneumoniae PACE provides funding and support for innovative, high value, high risk, early phase drug discovery and diagnostic projects Glasgow, UK, 20 November...
COPD management: a critical look at gaps in pharmaceutical innovation
Chronic Obstructive Pulmonary Disease (COPD) presents a major global health challenge, marked by chronic respiratory decline and frequent exacerbations. Despite advances in treatment, comprehensive management strategies remain limited, revealing significant gaps in patient care. ...
Mursla Bio’s EvoLiver surpasses current standards in liver cancer surveillance, data presented at AASLD Liver Meeting 2024
EvoLiver™ demonstrated 86% early-stage sensitivity at 88% specificity for liver cancer surveillance among cirrhotic, high-risk patients with diverse etiologies Validates clinical value of multi-omics content in organ-specific extracellular vesicles for liver cancer detection Data pr...
First ever UK-wide project launched to explore the inequality in access to psychological care within childhood brain tumour services
A pilot year-long project studying the inequality in access to psychological care within childhood brain tumour services, and the implications on access to clinical trials, has been launched by a team at the Great North Children’s Hospital in Newcastle. The project has been funded by ch...
Cleancube Multi: Guardtech Group’s shipping container facilities helping NHS Aseptic Pharmacies MOVE forward
Suffolk contamination control experts’ award-winning Cleancube Mobile Cleanrooms proving to be perfect solution for Trusts that require facility upgrades ...
100 guests including local sixth form students attend International Men's Day talks and wellbeing workshop at SBC
We were delighted to welcome over 100 guests to International Men’s Day at Stevenage Bioscience Catalyst. As part of our series of diversity and inclusion events this year, which have included International Women’s Day and PRIDE, we hosted talks, a Q&A and a wellbeing workshop to pr...